Standard BioTools to Participate in Upcoming Investor Conferences
31 Oktober 2024 - 1:01PM
Standard BioTools Inc. (NASDAQ: LAB) today announced that its
management team will participate in the following investor
conferences in the month of November:
- UBS Global
Healthcare Conference on November 12th,
2024President and CEO, Michael Egholm, PhD, will
participate in a corporate presentation on Tuesday, November 12,
2024, at 1:15 p.m. PT
- Jefferies
London Healthcare Conference on November 19th –
21st, 2024President and CEO, Michael
Egholm, PhD, will participate in a corporate presentation on
Tuesday, November 19, 2024, at 8:30 a.m. GMT
Available presentations will be webcast live and
available on the Investor Relations page of the Company’s website
at Events & Presentations. A recording will be archived and
available on the Standard BioTools Investor Relations page at
investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq: LAB), the parent company of
SomaLogic Inc. and previously known as Fluidigm Corporation, has an
established portfolio of essential, standardized next-generation
technologies that help biomedical researchers develop medicines
faster and better. As a leading solutions provider, the company
provides reliable and repeatable insights in health and disease
using its proprietary mass cytometry and microfluidics
technologies, which help transform scientific discoveries into
better patient outcomes. Standard BioTools works with leading
academic, government, pharmaceutical, biotechnology, plant and
animal research and clinical laboratories worldwide, focusing on
the most pressing needs in translational and clinical research,
including oncology, immunology and immunotherapy. Learn more at
standardbio.com or connect with us on X, Facebook®, LinkedIn, and
YouTube™.
For Research Use Only. Not for use in diagnostic procedures.
Limited Use Label License and other terms may apply:
standardbio.com/legal/salesterms.Patent and License Information:
standardbio.com/legal/notices. Trademarks:
standardbio.com/legal/trademarks. Any other trademarks are the sole
property of their respective owners. ©2024 Standard BioTools Inc.
(f.k.a. Fluidigm Corporation). All rights reserved.
Investor Contact
David HolmesGilmartin Group LLCir@standardbio.com
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
Von Dez 2023 bis Dez 2024